Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00253383 · ClinicalTrials.gov registry record · NA

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
329
Enrollment target

NCT00253383 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 329 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00253383, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
329 participants
Enrollment target

Study Summary

RATIONALE: Palliative care may help patients with advanced cancer live more comfortably. PURPOSE: This randomized clinical trial is studying an early intervention palliative care program to see how well it works compared to a standard care program in improving end-of-life care in patients with advanced lung , gastrointestinal, genitourinary, or breast cancer.

Interventions

  • PROCEDURE quality-of-life assessment
  • OTHER educational intervention
  • OTHER counseling intervention
  • PROCEDURE psychosocial assessment and care

Trial Details

FieldValue
Enrollment Target 329 participants
Start Date 2003-01
Est. Completion 2013-09
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT00253383

The ClinicalTrials.gov registry entry for NCT00253383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which quality-of-life assessment is the first listed.

NCT00253383 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00253383 about?

NCT00253383 is a clinical study titled "Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients". RATIONALE: Palliative care may help patients with advanced cancer live more comfortably. PURPOSE: This randomized clinical trial is studying an early intervention palliative care program to see how well it works compared to a standard care program in improving end-of-life care in patients with adva...

What is the current status of trial NCT00253383?

This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2003-01. Estimated completion is 2013-09.

What interventions are being tested in trial NCT00253383?

The interventions under investigation include: quality-of-life assessment (PROCEDURE), educational intervention (OTHER), counseling intervention (OTHER), psychosocial assessment and care (PROCEDURE).

Who is sponsoring clinical trial NCT00253383?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.